✦ LIBER ✦

PD-157 Serum EGFR in patients with non-small cell lung cancer(NSCLC) treated with gefitinib

✍ Scribed by Spreafico, A.; Gregorc, V.; Ludovini, V.; Pistola, L.; Amoroso, M.; Tofanetti, F.; Compagnoni, A.; Aondio, G.; Tonato, M.; Villa, E.

Book ID: 118572904
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 149 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(05)80490-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gefitinib (ZD1839): Therapy in selected

Gefitinib (ZD1839): Therapy in selected patients with non-small cell lung cancer (NSCLC)?

✍ Dongiovanni, Diego; Daniele, Lorenzo; Barone, Carla; Dongiovanni, Vincenzo; Fiss 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Predictive factors associated with prolo

Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib

✍ Satouchi, M; Negoro, S; Funada, Y; Urata, Y; Shimada, T; Yoshimura, S; Kotani, Y 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 123 KB

Polymorphisms of EGFR predict clinical o

Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib

✍ Ma, Fei; Sun, Tong; Shi, Yuankai; Yu, Dianke; Tan, Wen; Yang, Ming; Wu, Chen; Ch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 547 KB

PD-151 Mutations in the epidermal growth

PD-151 Mutations in the epidermal growth factor receptor (EGFR): Retro-and prospective observations in non-small cell lung cancer (NSCLC) patients (pts) treated with gefitinib

✍ Nederlof, P.; Boerrigter, L.; van 't Veer, L.; Baas, P.; van Zandwijk, N. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Gefitinib or Chemotherapy for Non–Small-

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

✍ Maemondo, Makoto; Inoue, Akira; Kobayashi, Kunihiko; Sugawara, Shunichi; Oizumi, 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 341 KB

Gefitinib or Chemotherapy for Non–Small-

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

✍ Maemondo, Makoto; Inoue, Akira; Kobayashi, Kunihiko; Sugawara, Shunichi; Oizumi, 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 341 KB

## Background: Non-small-cell lung cancer with sensitive mutations of the epidermal growth factor receptor (egfr) is highly responsive to egfr tyrosine kinase inhibitors such as gefitinib, but little is known about how its efficacy and safety profile compares with that of standard chemotherapy. ##